itel to Unveil Flagship Smartphone S23+: A Fusion of Curved Screen Elegance and Exceptional Performance
SHENZHEN, China--(BUSINESS WIRE)--#AI--itel, the global leading smart life brand committed to providing affordable and good-quality…
3 years ago
Alex
KKR to Acquire 20% Stake in Singtel’s Regional Data Centre Business Valued at S$5.5 Billion
SINGAPORE--(BUSINESS WIRE)--Singtel, Asia's leading communications technology group, and leading global investment firm KKR have reached…
3 years ago
2023 World Manufacturing Convention to Be Held in Hefei, Anhui from September 20th to 24th
HEFEI, China--(BUSINESS WIRE)--The 2023 World Manufacturing Convention is set to take place in Hefei, Anhui…
3 years ago
The Aesthetic Revolution: Your Insider’s Guide to the Beauty Industry
The beauty industry is a multi-faceted domain, boasting a rich history and a promising future.…
3 years ago
SAGALIAM ACQUISITION CORP. ANNOUNCES EXECUTION OF DEFINITIVE BUSINESS COMBINATION AGREEMENT AND RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER
New York, NY, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAUâ€, “SAGAâ€,…
3 years ago
NSSC INVESTOR NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – NSSC
NEW YORK--(BUSINESS WIRE)--$NSSC #NSSC--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers…
3 years ago
Gallium Semiconductor Expands Portfolio With First ISM CW Amplifier
The GTH2e-2425300P delivers best-in-class broadband efficiency (>72%) and RF performance for ISM applications in a…
3 years ago
AM Best Removes Under Review With Negative Implications Status and Affirms Credit Ratings of Hotai Insurance Co., Ltd.
HONG KONG--(BUSINESS WIRE)--AM Best has removed from under review with negative implications and affirmed the…
3 years ago
ENHERTU® Recommended for Approval in the EU by CHMP for Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer
Recommendation based on DESTINY-Lung02 trial results, which showed Daiichi Sankyo and AstraZeneca’s ENHERTU achieved strong…
3 years ago
Quizartinib Recommended for Approval in EU by CHMP for Patients with Newly Diagnosed FLT3-ITD Positive AML
Positive opinion based on QuANTUM-First results demonstrating quizartinib combined with standard chemotherapy improved overall survival…
3 years ago